A carregar...

Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience

BACKGROUND: HER2/neu overexpression and/or amplification has been widely studied in a number of solid tumors, primarily in the breast. In gynecologic neoplasms, determination of HER2/neu status has not been well studied as a predictive biomarker in anti-HER2/neu treatment. METHODS: We systematically...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diagn Pathol
Main Authors: Woo, Jennifer S., Apple, Sophia K., Sullivan, Peggy S., Rao, Jian-Yu, Ostrzega, Nora, Moatamed, Neda A.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5075405/
https://ncbi.nlm.nih.gov/pubmed/27770810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-016-0553-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!